Design Therapeutics Inc (DSGN)
4.14
-0.26
(-5.91%)
USD |
NASDAQ |
May 21, 16:00
4.00
-0.14
(-3.38%)
After-Hours: 20:00
Design Therapeutics Total Liabilities (Quarterly): 9.236M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.236M |
| December 31, 2023 | 11.96M |
| September 30, 2023 | 14.91M |
| June 30, 2023 | 14.84M |
| March 31, 2023 | 11.92M |
| December 31, 2022 | 13.83M |
| September 30, 2022 | 13.63M |
| Date | Value |
|---|---|
| June 30, 2022 | 10.77M |
| March 31, 2022 | 8.492M |
| December 31, 2021 | 8.427M |
| September 30, 2021 | 8.789M |
| June 30, 2021 | 3.545M |
| March 31, 2021 | 3.848M |
| December 31, 2020 | 47.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.545M
Minimum
Jun 2021
47.83M
Maximum
Dec 2020
13.00M
Average
11.35M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 278.79M |
| Shareholders Equity (Quarterly) | 269.56M |